CVS expects elevated medical costs to continue to pressure its performance this year, “and as a result we are not providing a formal outlook at this time.”
Recent Posts
- No buy, low buy, slow buy: How many consumers are preparing for an economic hit
- Trump suggests cutting China tariff to still-high 80% ahead of U.S.-Beijing trade talks
- Cargo thieves are attacking the U.S. supply chain at alarming rates
- Palantir now among 10 most valuable U.S. tech companies — its earnings multiple is astronomical
- This financial stock is poised to ‘make a lot of money,’ says Miller Tabak’s Matt Maley